To improve the clinical potential of this antibody, in this study, we evaluated the therapeutic potential of Ab27 using endogenous or stably TM4SF5-expressing liver and colon cancer cells in vivo and in vitro. Here, TM4SF5 is linked to colonic neoplasm.